Hyo Seon Yu

Hyo Seon Yu

Auto-generated profile, based on publicly available information

Hyo Seon Yu

Department of Ophthalmology Hanyang University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2020 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
HYHyo Seon Yu
Hyo Seon Yu
EHEun Hee Hong
Eun Hee Hong
YSYong Un SHIN
Yong Un SHIN
Seong-Ho KohSeong-Ho Koh
Seong-Ho Koh
HCHee Yoon Cho
Hee Yoon Cho
Click on the article title to read more.

1 January 2024 in Journal of Ophthalmology
Verified
Journal Article
Open access
JKJi Hong Kim
Ji Hong Kim
HYHyoseon Yu
Hyoseon Yu
JKJi Hye Kang
Ji Hye Kang
EHEun Hee Hong
Eun Hee Hong
MKMIn Ho Kang
MIn Ho Kang
YSYong Un SHIN
Yong Un SHIN
Purpose. This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes‐induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR). Methods. To establish diabetes‐induced cell models, ARPE‐19 cells were treated with high glucose. The expression levels of five miRNAs (miR‐185, miR‐17, miR‐20a, miR‐15a, and miR‐15b) were measured in high glucose‐treated ARPE‐19 cells using real‐time quantitative polymerase chain reaction. Western blotting was performed to measure inflammasome expression in cellular models. miR‐17 was selected as the target miRNA, and inflammasome expression was measured following the transfection of an miR‐17 mimic into high glucose‐treated ARPE‐19 cells. Results. In high glucose‐treated ARPE‐19 cells, miRNA expression was substantially downregulated, whereas that of inflammasome components was significantly increased. Following the transfection of the miR‐17 mimic into high glucose‐treated ARPE‐19 cells, the levels of inflammasome components were significantly decreased. Conclusions. This study investigated the relationship between miRNAs and inflammasomes in diabetes‐induced cells using high glucose‐treated ARPE‐19 cells. These findings suggested that miR‐17 suppresses inflammasomes, thereby reducing the subsequent inflammatory response and indicating that miRNAs and inflammasomes could serve as new therapeutic targets for DR.